Project Grant HT94252410285
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$2.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Galveston, TX 77555, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
This $317,001 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) will support the University of Texas at Austin's investigation of clot mechanics in pulmonary failure and thromboembolic disease in sickle cell anemia. The research aims to improve understanding and treatment of these conditions, which are of high relevance to military medicine. The 2-year project will leverage the university's...
This $818,337 federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research on extended limb stasis in the Encore Tissue Preservation Device. The research, conducted by Vascular Perfusion Solutions Inc., a self-certified small disadvantaged business located in San Antonio, TX, aims to advance medical solutions for military personnel and the broader public. The award, with a performance period from...
The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This $999,392 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research initiatives at the University of Houston System. The funding will be used to conduct research on PRMT5 in lupus nephritis, with a performance period from September 1, 2025 through August 31, 2029. The Military Medical Research and Development program focuses on transforming healthcare for military service...
The University of Texas Health Science Center of San Antonio was awarded a $620,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from May 2022 through April 2026 to target the lysosomal acid lipase A enzyme to induce cellular stress in ovarian cancer. As part of the Military Medical Research and Development program's goals to transform military and public...
The University of Texas Medical Branch at Galveston (UTMB) was awarded a $2,410,969 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through August 2025 to develop non-opioid chronic pain treatments by erasing spinal pain memory. As part of the Military Medical Research and Development program's goals to transform military and public health through innovative medical...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $1,559,997.00 Project Grant under the Department of the Army Medical Command's Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 1, 2024 to August 31, 2027, will fund a pharmacology and efficacy study of a novel blood-brain barrier (BBB)-permeable agent for the treatment of breast cancer brain metastases. UTHealth, a state-controlled...
The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The...
The University of Texas Southwestern Medical Center was awarded a $1,639,308 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2025 to repurpose MEK-inhibitors for the treatment of lymphatic malformations. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through...